Marshall Wace’s Chembio diagnostics, Inc. CEMI Stock Holding History

Marshall Wace’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,977	Closed	-$33K	–	3688
2021 Q2	$33K	Buy	+10,977	New	+$38.3K	﹤0.01%	2580
2021 Q1	–	Sell	-176,981	Closed	-$841K	–	3097
2020 Q4	$841K	Buy	+176,981	New	+$914K	﹤0.01%	1280
2019 Q1	–	Sell	-15,079	Closed	-$85K	–	2284
2018 Q4	$85K	Buy	+15,079	New	+$111K	﹤0.01%	1394

Other funds holding CEMI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marshall Wace's CEMI Position: Q3 2021 in Review

Marshall Wace sold out of Chembio diagnostics, Inc. (CEMI) in Q3 2021, closing a stake of 10,977 shares — an estimated $33K sold.

Marshall Wace first reported a position in CEMI in Q4 2018 and held it in 3 quarters. The position peaked at $841K in Q4 2020. 47 funds tracked by Wall St. Rank hold CEMI as of Q3 2021.

Marshall Wace reported no remaining Chembio diagnostics, Inc. position as of Q3 2021 after selling out during the quarter.
Marshall Wace sold 10,977 Chembio diagnostics, Inc. shares in Q3 2021, an estimated $33K.
Marshall Wace first reported a position in Chembio diagnostics, Inc. in Q4 2018 and held it in 3 quarters.
Marshall Wace's Chembio diagnostics, Inc. position peaked at $841K in Q4 2020.
47 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q3 2021.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.